{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T06:22:03Z","timestamp":1783059723009,"version":"3.54.6"},"reference-count":37,"publisher":"American Association for Cancer Research (AACR)","issue":"9","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,5,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Current treatments of sporadic Burkitt's lymphoma (sBL) are associated with severe toxicities. A better understanding of sBL formation would facilitate development of less toxic therapies. The etiology of sBL remains, however, largely unknown, C-MYC up-regulation being the only lesion known to occur in all sBL cases. Several studies examining the role of C-MYC in the pathogenesis of BL have concluded that C-MYC translocation is not the only critical event and that additional unidentified factors are expected to be involved in the formation of this tumor. We herein report that a gene distinct from C-MYC, E2F1, is involved in the formation of all or most sBL tumors. We found that E2F1 is highly expressed in Burkitt's lymphoma cell lines and sBL lymphoma specimens. Our data indicate that its elevated expression is not merely the consequence of the presence of more cycling cells in this tumor relative to other cell lines or to other neoplasias. In fact, we show that reduction of its expression in sBL cells inhibits tumor formation and decreases their proliferation rate. We also provide data suggesting that E2F1 collaborates with C-MYC in sBL formation. E2F1 expression down-regulation did not affect, however, the proliferation of human primary diploid fibroblasts. Because E2F1 is not needed for cell proliferation of normal cells, our results reveal E2F1 as a promising therapeutic target for sBL. [Cancer Res 2009;69(9):4052\u20138]<\/jats:p>","DOI":"10.1158\/0008-5472.can-08-4617","type":"journal-article","created":{"date-parts":[[2009,4,30]],"date-time":"2009-04-30T03:37:43Z","timestamp":1241062663000},"page":"4052-4058","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["<i>E2F1<\/i>\n                    Expression Is Deregulated and Plays an Oncogenic Role in Sporadic Burkitt's Lymphoma"],"prefix":"10.1158","volume":"69","author":[{"given":"Irene","family":"Molina-Privado","sequence":"first","affiliation":[{"name":"1Instituto de Investigaciones Biome\u0301dicas de Madrid, Consejo Superior de Investigaciones Cienti\u0301ficas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u0301a","family":"Rodri\u0301guez-Marti\u0301nez","sequence":"additional","affiliation":[{"name":"1Instituto de Investigaciones Biome\u0301dicas de Madrid, Consejo Superior de Investigaciones Cienti\u0301ficas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Rebollo","sequence":"additional","affiliation":[{"name":"1Instituto de Investigaciones Biome\u0301dicas de Madrid, Consejo Superior de Investigaciones Cienti\u0301ficas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Marti\u0301n-Pe\u0301rez","sequence":"additional","affiliation":[{"name":"2Centro Nacional de Investigaciones Oncolo\u0301gicas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u0301a-Jesu\u0301s","family":"Artiga","sequence":"additional","affiliation":[{"name":"2Centro Nacional de Investigaciones Oncolo\u0301gicas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mena\u0301rguez","sequence":"additional","affiliation":[{"name":"3Hospital Gregorio Maran\u0303o\u0301n, Madrid, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K.","family":"Flemington","sequence":"additional","affiliation":[{"name":"4Tulane Health Sciences Center, New Orleans, Louisiana"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[{"name":"2Centro Nacional de Investigaciones Oncolo\u0301gicas;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel R.","family":"Campanero","sequence":"additional","affiliation":[{"name":"1Instituto de Investigaciones Biome\u0301dicas de Madrid, Consejo Superior de Investigaciones Cienti\u0301ficas;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2009,4,30]]},"reference":[{"key":"2022061701472953600_B1","doi-asserted-by":"crossref","unstructured":"Shapira J, Peylan-Ramu N. Burkitt's lymphoma. Oral Oncol\u20081998; 34: 15\u201323.","DOI":"10.1016\/S1368-8375(97)00041-9"},{"key":"2022061701472953600_B2","doi-asserted-by":"crossref","unstructured":"Yustein JT, Dang CV. Biology and treatment of Burkitt's lymphoma. Curr Opin Hematol\u20082007; 14: 375\u201381.","DOI":"10.1097\/MOH.0b013e3281bccdee"},{"key":"2022061701472953600_B3","doi-asserted-by":"crossref","unstructured":"Patte C, Auperin A, Gerrard M, et al. Results of the randomized international FAB\/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients. Blood\u20082007; 109: 2773\u201380.","DOI":"10.1182\/blood-2006-07-036673"},{"key":"2022061701472953600_B4","doi-asserted-by":"crossref","unstructured":"Hecht JL, Aster JC. Molecular biology of Burkitt's lymphoma. J Clin Oncol\u20082000; 18: 3707\u201321.","DOI":"10.1200\/JCO.2000.18.21.3707"},{"key":"2022061701472953600_B5","doi-asserted-by":"crossref","unstructured":"Hotchin NA, Allday MJ, Crawford DH. Deregulated c-myc expression in Epstein-Barr-virus-immortalized B-cells induces altered growth properties and surface phenotype but not tumorigenicity. Int J Cancer\u20081990; 45: 566\u201371.","DOI":"10.1002\/ijc.2910450332"},{"key":"2022061701472953600_B6","doi-asserted-by":"crossref","unstructured":"Johnson DG, Schneider-Broussard R. Role of E2F in cell cycle control and cancer. Front Biosci\u20081998; 3: 447\u201358.","DOI":"10.2741\/A291"},{"key":"2022061701472953600_B7","doi-asserted-by":"crossref","unstructured":"DeGregori J. The genetics of the E2F family of transcription factors: shared functions and unique roles. Biochim Biophys Acta\u20082002; 1602: 131\u201350.","DOI":"10.1016\/S0304-419X(02)00051-3"},{"key":"2022061701472953600_B8","doi-asserted-by":"crossref","unstructured":"Tsantoulis PK, Gorgoulis VG. Involvement of E2F transcription factor family in cancer. Eur J Cancer\u20082005; 41: 2403\u201314.","DOI":"10.1016\/j.ejca.2005.08.005"},{"key":"2022061701472953600_B9","doi-asserted-by":"crossref","unstructured":"Futterer A, Campanero MR, Leonardo E, et al. Dido gene expression alterations are implicated in the induction of hematological myeloid neoplasms. J Clin Invest\u20082005; 115: 2351\u201362.","DOI":"10.1172\/JCI24177"},{"key":"2022061701472953600_B10","unstructured":"Jaffe ES, Harris NL, Stein H, Vardiman JW. Pathology and genetics of tumours of haematopoietic and lymphoid tissues. Lyon (France): IARC Press; 2001."},{"key":"2022061701472953600_B11","doi-asserted-by":"crossref","unstructured":"Campanero MR, Flemington EK. Regulation of E2F through ubiquitin-proteasome-dependent degradation: stabilization by the pRB tumor suppressor protein. Proc Natl Acad Sci U S A\u20081997; 94: 2221\u20136.","DOI":"10.1073\/pnas.94.6.2221"},{"key":"2022061701472953600_B12","doi-asserted-by":"crossref","unstructured":"Campanero MR, Armstrong M, Flemington E. Distinct cellular factors regulate the c-myb promoter through its E2F element. Mol Cell Biol\u20081999; 19: 8442\u201350.","DOI":"10.1128\/MCB.19.12.8442"},{"key":"2022061701472953600_B13","doi-asserted-by":"crossref","unstructured":"Ross DT, Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines. Nat Genet\u20082000; 24: 227\u201335.","DOI":"10.1038\/73432"},{"key":"2022061701472953600_B14","doi-asserted-by":"crossref","unstructured":"Thorley-Lawson DA, Allday MJ. The curious case of the tumour virus: 50 years of Burkitt's lymphoma. Nat Rev Microbiol\u20082008; 6: 913\u201324.","DOI":"10.1038\/nrmicro2015"},{"key":"2022061701472953600_B15","doi-asserted-by":"crossref","unstructured":"Nilsson K, Giovanella BC, Stehlin JS, Klein G. Tumorigenicity of human hematopoietic cell lines in athymic nude mice. Int J Cancer\u20081977; 19: 337\u201344.","DOI":"10.1002\/ijc.2910190309"},{"key":"2022061701472953600_B16","doi-asserted-by":"crossref","unstructured":"Ben-Bassat H, Goldblum N, Mitrani S, et al. Establishment in continuous culture of a new type of lymphocyte from a \u201cBurkitt like\u201d malignant lymphoma (line D.G.-75). Int J Cancer\u20081977; 19: 27\u201333.","DOI":"10.1002\/ijc.2910190105"},{"key":"2022061701472953600_B17","doi-asserted-by":"crossref","unstructured":"Felsher DW, Zetterberg A, Zhu J, Tlsty T, Bishop JM. Overexpression of MYC causes p53-dependent G2 arrest of normal fibroblasts. Proc Natl Acad Sci U S A\u20082000; 97: 10544\u20138.","DOI":"10.1073\/pnas.190327097"},{"key":"2022061701472953600_B18","doi-asserted-by":"crossref","unstructured":"Packham G, Cleveland JL. c-Myc and apoptosis. Biochim Biophys Acta\u20081995; 1242: 11\u201328.","DOI":"10.1016\/0304-419X(94)00015-T"},{"key":"2022061701472953600_B19","doi-asserted-by":"crossref","unstructured":"Cam H, Dynlacht BD. Emerging roles for E2F: beyond the G1\/S transition and DNA replication. Cancer Cell\u20082003; 3: 311\u20136.","DOI":"10.1016\/S1535-6108(03)00080-1"},{"key":"2022061701472953600_B20","doi-asserted-by":"crossref","unstructured":"Seguin L, Liot C, Mzali R, et al. CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP and MKLP1 in S-phase. Mol Cell Biol 2009;29:570\u201381.","DOI":"10.1128\/MCB.01275-08"},{"key":"2022061701472953600_B21","doi-asserted-by":"crossref","unstructured":"Campanero MR. Mechanisms involved in Burkitt's tumor formation. Clin Transl Oncol\u20082008; 10: 250\u20135.","DOI":"10.1007\/s12094-008-0193-x"},{"key":"2022061701472953600_B22","doi-asserted-by":"crossref","unstructured":"Dave SS, Fu K, Wright GW, et al. Molecular diagnosis of Burkitt's lymphoma. N Engl J Med\u20082006; 354: 2431\u201342.","DOI":"10.1056\/NEJMoa055759"},{"key":"2022061701472953600_B23","doi-asserted-by":"crossref","unstructured":"Hummel M, Bentink S, Berger H, et al. A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling. N Engl J Med\u20082006; 354: 2419\u201330.","DOI":"10.1056\/NEJMoa055351"},{"key":"2022061701472953600_B24","unstructured":"Zhang SY, Liu SC, Al-Saleem LF, et al. E2F-1: a proliferative marker of breast neoplasia. Cancer Epidemiol Biomarkers Prev\u20082000; 9: 395\u2013401."},{"key":"2022061701472953600_B25","doi-asserted-by":"crossref","unstructured":"Zacharatos P, Kotsinas A, Evangelou K, et al. Distinct expression patterns of the transcription factor E2F-1 in relation to tumour growth parameters in common human carcinomas. J Pathol\u20082004; 203: 744\u201353.","DOI":"10.1002\/path.1582"},{"key":"2022061701472953600_B26","unstructured":"Hunt KK, Deng J, Liu TJ, et al. Adenovirus-mediated overexpression of the transcription factor E2F-1 induces apoptosis in human breast and ovarian carcinoma cell lines and does not require p53. Cancer Res\u20081997; 57: 4722\u20136."},{"key":"2022061701472953600_B27","doi-asserted-by":"crossref","unstructured":"Hao H, Dong Y, Bowling MT, Gomez-Gutierrez JG, Zhou HS, McMasters KM. E2F-1 induces melanoma cell apoptosis via PUMA up-regulation and Bax translocation. BMC Cancer\u20082007; 7: 24.","DOI":"10.1186\/1471-2407-7-24"},{"key":"2022061701472953600_B28","unstructured":"Bramis J, Zacharatos P, Papaconstantinou I, et al. E2F-1 transcription factor immunoexpression is inversely associated with tumor growth in colon adenocarcinomas. Anticancer Res\u20082004; 24: 3041\u20137."},{"key":"2022061701472953600_B29","doi-asserted-by":"crossref","unstructured":"Teitell MA. The TCL1 family of oncoproteins: co-activators of transformation. Nat Rev Cancer\u20082005; 5: 640\u20138.","DOI":"10.1038\/nrc1672"},{"key":"2022061701472953600_B30","doi-asserted-by":"crossref","unstructured":"Ishida S, Huang E, Zuzan H, et al. Role for E2F in control of both DNA replication and mitotic functions as revealed from DNA microarray analysis. Mol Cell Biol\u20082001; 21: 4684\u201399.","DOI":"10.1128\/MCB.21.14.4684-4699.2001"},{"key":"2022061701472953600_B31","doi-asserted-by":"crossref","unstructured":"Polager S, Kalma Y, Berkovich E, Ginsberg D. E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis. Oncogene\u20082002; 21: 437\u201346.","DOI":"10.1038\/sj.onc.1205102"},{"key":"2022061701472953600_B32","doi-asserted-by":"crossref","unstructured":"Ren B, Cam H, Takahashi Y, et al. E2F integrates cell cycle progression with DNA repair, replication, and G(2)\/M checkpoints. Genes Dev\u20082002; 16: 245\u201356.","DOI":"10.1101\/gad.949802"},{"key":"2022061701472953600_B33","doi-asserted-by":"crossref","unstructured":"Neufeld TP, de la Cruz AF, Johnston LA, Edgar BA. Coordination of growth and cell division in the Drosophila wing. Cell\u20081998; 93: 1183\u201393.","DOI":"10.1016\/S0092-8674(00)81462-2"},{"key":"2022061701472953600_B34","doi-asserted-by":"crossref","unstructured":"Zhu W, Giangrande PH, Nevins JR. E2Fs link the control of G1\/S and G2\/M transcription. EMBO J\u20082004; 23: 4615\u201326.","DOI":"10.1038\/sj.emboj.7600459"},{"key":"2022061701472953600_B35","doi-asserted-by":"crossref","unstructured":"Field SJ, Tsai FY, Kuo F, et al. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell\u20081996; 85: 549\u201361.","DOI":"10.1016\/S0092-8674(00)81255-6"},{"key":"2022061701472953600_B36","doi-asserted-by":"crossref","unstructured":"Yamasaki L, Jacks T, Bronson R, Goillot E, Harlow E, Dyson NJ. Tumor induction and tissue atrophy in mice lacking E2F-1. Cell\u20081996; 85: 537\u201348.","DOI":"10.1016\/S0092-8674(00)81254-4"},{"key":"2022061701472953600_B37","doi-asserted-by":"crossref","unstructured":"DeRyckere D, DeGregori J. E2F1 and E2F2 are differentially required for homeostasis-driven and antigen-induced T cell proliferation in vivo. J Immunol\u20082005; 175: 647\u201355.","DOI":"10.4049\/jimmunol.175.2.647"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/9\/4052\/2623133\/4052.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/69\/9\/4052\/2623133\/4052.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T04:46:23Z","timestamp":1655441183000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/69\/9\/4052\/553001\/E2F1-Expression-Is-Deregulated-and-Plays-an"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,4,30]]},"references-count":37,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2009,4,30]]},"published-print":{"date-parts":[[2009,5,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-08-4617","relation":{"is-supplemented-by":[{"id-type":"doi","id":"10.1158\/0008-5472.22381001.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380998","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380995.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380998.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381004","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381001","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381013.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381013","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381007","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22380995","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381004.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22381007.v1","asserted-by":"object"}],"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6499730.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6499730","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,4,30]]}}}